Skip to content

13F-HR filed by GENERAL ATLANTIC, L.P.

GENERAL ATLANTIC, L.P. filed this 13F-HR for the quarter ended 2026-03-31, filed 2026-05-15, with 12 holding rows worth $2,148,421,589.

Accession
0000950142-26-001406
Filed
2026-05-15
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2026

A holdings report, 12 entries on the cover page, a total value of $2,148,421,589 stated on the cover page (in dollars after the unit check, H1), rows summing to $2,148,421,589 with VALUE read as dollars as filed, 13F file number 028-03473. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
DLOCAL LTDG29018101CLASS A COM46,656,695$605,137,334dollars as filed
CHIME FINL INC COM SHS CL A16935C109Stock21,259,683$398,193,863dollars as filed
XP INC CL AG98239109Stock20,566,133$391,579,172dollars as filed
ALKAMI TECHNOLOGY INC01644J108COM15,337,495$240,338,547dollars as filed
PHARVARIS NVN69605108COMMON STOCK8,031,252$226,882,869dollars as filed
EUROPEAN WAX CTR INC29882P106CLASS A COM13,110,492$75,778,644dollars as filed
REVOLUTION MEDICINES INC COM76155X100Stock707,791$68,832,675dollars as filed
NURIX THERAPEUTICS INC67080M103COMMON STOCK4,101,865$63,578,908dollars as filed
CENTESSA PHARMACEUTICALS PLC152309100SPONSORED ADS1,354,830$53,813,848dollars as filed
RISKIFIED LTD AM8216R109COMMON STOCK5,324,998$20,873,992dollars as filed
GROVE COLLABORATIVE HOLDINGS39957D201Common Stock2,474,859$3,167,820dollars as filed
WEBULL CORPG9572D103ORD SHS50,816$243,917dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0000950142-26-001406this filing2026-05-15acceptance time not in the bulk data set